| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NEXIUM IV | 021689 | 001 | NDA | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No | 2005/03/31 | 2005/03/31 | ASTRAZENECA | Discontinued |
| NEXIUM IV | 021689 | 002 | NDA | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | EQ 40MG BASE/VIAL | Yes | Yes | 2005/03/31 | 2005/03/31 | ASTRAZENECA | Prescription |